Results 161 to 170 of about 5,544 (172)

Determinants of the Clinical Outcomes of Gout During the First Year of Urate-Lowering Therapy

Nucleosides, Nucleotides and Nucleic Acids, 2008
Patricia A Macdonald, Nancy Joseph-Ridge   +1 more
exaly  

Dual‐energy computed tomography for monitoring the effect of urate‐lowering therapy in gouty arthritis

International Journal of Rheumatic Diseases, 2015
Ying Sun, Huiyong Chen, Zhuojun Zhang
exaly  

Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study

Rheumatology, 2019
Esther Ebstein, Marine Forien, Pascal Richette   +2 more
exaly  

Prophylaxis for acute gout flares after initiation of urate-lowering therapy

Rheumatology, 2014
Augustin Latourte, Thomas Bardin, Pascal Richette   +2 more
exaly  

Improving adherence to urate‐lowering therapy in people living with gout

International Journal of Rheumatic Diseases, 2019
Matthew J, Coleshill, Eindra, Aung, Amy D, Nguyen, Sophie L, Stocker, Melissa T, Baysari, Bishoy, Kamel, Marcel, Schulz, Andrew J, McLachlan, Richard O, Day   +8 more
openaire   +2 more sources

Salivary uric acid as a noninvasive biomarker for monitoring the efficacy of urate-lowering therapy in a patient with chronic gouty arthropathy

Clinica Chimica Acta, 2015
Ying Huang
exaly  

Association between urate-lowering therapy and kidney failure in patients with chronic kidney disease

Journal of Nephrology
Dorothee Cannet, Celine Lange, Pascal Morel   +2 more
exaly  

EPH46 Urate Lowering Therapy in Patients With Subcutaneous Tophi

Value in Health
R Morlock, R.T. Keenan
openaire   +1 more source

Is fracture risk linked to gout or urate-lowering therapy?

Drug and Therapeutics Bulletin, 2019
openaire   +2 more sources

An updated systematic review and meta-analysis of randomised controlled trials on the effects of urate-lowering therapy initiation during a gout flare

Seminars in Arthritis and Rheumatism
Vicky Tai, Peter Gow, Sarah Stewart
exaly